Cire Ciwon Madara
Cikakken Bayani:
Sunan Samfura: Cire Wannan Madara
Lambar CAS: 22888-70-6
Tsarin kwayoyin halitta: C25H22O10
Nauyin Kwayoyin: 482.436
Bayyanar: Yellow lafiya foda
Hanyar Cire: Barasa mai hatsi
Solubility: mafi kyawun narkewar ruwa
Hanyar gwaji:HPLC
Musammantawa: 40% ~ 80% Silymarin UV, 30% Silibinin+Isosilybin
Bayani
Silymarin wani hadadden flavonoid ne na musamman - yana dauke da silybin, silydianin, da silychrisin - wanda aka samu daga wannan shukar madara.
Rashin narkewar ruwa mara kyau da kuma bioavailability na silymarinled don haɓaka haɓakar abubuwan ƙira.sabon hadadden silybin da phospholipids na halitta an haɓaka.Wannan ingantaccen samfurin ana san shi da sunan Silyphos.Ta hanyar hada silybin tare da phospholipids, masana kimiyya sun sami damar yin silybin zuwa wani nau'i mai narkewa kuma mafi kyawun sha.Wannan silybin/phospholipid hadaddun (Silyphos) an gano yana da ingantaccen ingantaccen rayuwa, har sau goma mafi kyawun sha, da inganci.
Aikace-aikace
Kariyar hanta
Anti Free radicals
Antioxidant
Anti-mai kumburi
Rigakafin ciwon daji na fata
Magani, kari na abinci, Amfanin Lafiya: Busassun furannin sarƙaƙƙiya a ƙarshen bazara
An gane tsantsa daga cikin ƙarnuka da yawa na ƙwayar nono a matsayin "livertonics."An gudanar da bincike kan ayyukan nazarin halittu na silymarin da yiwuwar amfani da shi na likitanci a cikin ƙasashe da yawa tun daga shekarun 1970, amma ingancin binciken bai yi daidai ba.An ba da rahoton ƙwayar ƙwayar madara tana da tasirin kariya akan hanta kuma don inganta aikinta sosai.Ana amfani da ita don magance hanta, ciwon hanta na yau da kullum (ƙumburi na hanta), hanta mai guba mai lalacewa ciki har da rigakafin mummunar lalacewar hanta daga Amanita phalloides ('mutuwar mutuwa' guba na naman kaza), da cututtuka na gallbladder.
Bita na wallafe-wallafen da suka shafi nazarin asibiti na silymarin sun bambanta a ƙarshen su.Binciken da aka yi amfani da nazarin kawai tare da ka'idojin makafi biyu da placebo sun kammala cewa madarar nono da abubuwan da suka samo asali "ba su da tasiri sosai ga marasa lafiya da barasa da / ko ciwon hanta na hepatitis B ko C."Wani bita na wallafe-wallafen, wanda aka yi wa Ma'aikatar Lafiya da Sabis na Jama'a na Amurka, ya gano cewa, yayin da akwai ƙwaƙƙwaran shaidar fa'idodin kiwon lafiya, binciken da aka yi ya zuwa yau ba daidai ba ne da ƙima wanda babu tabbataccen sakamako game da matakan tasiri na takamaiman yanayi ko takamaiman yanayi. har yanzu ana iya yin adadin da ya dace.
